- Home
- ELDN vs EVC Comparison
ELDN vs EVC Comparison
Compare ELDN & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- EVC
- Stock Information
- Founded
- ELDN 2004
- EVC 1996
- Country
- ELDN United States
- EVC United States
- Employees
- ELDN N/A
- EVC N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- ELDN Health Care
- EVC Industrials
- Exchange
- ELDN Nasdaq
- EVC Nasdaq
- Market Cap
- ELDN 202.4M
- EVC 188.3M
- IPO Year
- ELDN N/A
- EVC 2000
- Fundamental
- Price
- ELDN $2.63
- EVC $2.47
- Analyst Decision
- ELDN Strong Buy
- EVC
- Analyst Count
- ELDN 2
- EVC 0
- Target Price
- ELDN $12.50
- EVC N/A
- AVG Volume (30 Days)
- ELDN 996.9K
- EVC 184.3K
- Earning Date
- ELDN 08-14-2025
- EVC 08-05-2025
- Dividend Yield
- ELDN N/A
- EVC 8.02%
- EPS Growth
- ELDN N/A
- EVC N/A
- EPS
- ELDN 0.21
- EVC N/A
- Revenue
- ELDN N/A
- EVC $396,704,000.00
- Revenue This Year
- ELDN N/A
- EVC $64.06
- Revenue Next Year
- ELDN N/A
- EVC N/A
- P/E Ratio
- ELDN $12.40
- EVC N/A
- Revenue Growth
- ELDN N/A
- EVC 25.34
- 52 Week Low
- ELDN $2.38
- EVC $1.58
- 52 Week High
- ELDN $5.54
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- ELDN 36.28
- EVC 53.83
- Support Level
- ELDN $2.54
- EVC $2.36
- Resistance Level
- ELDN $2.82
- EVC $2.52
- Average True Range (ATR)
- ELDN 0.21
- EVC 0.12
- MACD
- ELDN -0.08
- EVC 0.02
- Stochastic Oscillator
- ELDN 20.00
- EVC 61.32
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.